SECUKINUMAB
Biological
Novartis Pharma AG
Total Payments
$18,637
Transactions
18
Doctors
7
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $15,262 | 16 | 6 |
| 2017 | $3,375 | 2 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $8,530 | 5 | 45.8% |
| Unspecified | $6,731 | 10 | 36.1% |
| Consulting Fee | $3,240 | 1 | 17.4% |
| Food and Beverage | $136.60 | 2 | 0.7% |
Payments by Type
General
$11,906
8 transactions
Research
$6,731
10 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $6,731 | 4 |
Top Doctors Receiving Payments for SECUKINUMAB
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Dermatology | Somers, NY | $11,579 | 4 |
| , MD | Rheumatology | Portland, OR | $2,623 | 3 |
| , MD | Rheumatology | Duncansville, PA | $1,688 | 1 |
| , M.D | Rheumatology | Portola Valley, CA | $1,678 | 4 |
| , MD | Internal Medicine | Salt Lake City, UT | $743.17 | 2 |
| , MD | Rheumatology | Chicago, IL | $197.49 | 2 |
| , M.D | Allergy & Immunology | La Jolla, CA | $129.20 | 2 |
Ad
Manufacturing Companies
- Novartis Pharma AG $18,637
Product Information
- Type Biological
- Total Payments $18,637
- Total Doctors 7
- Transactions 18
About SECUKINUMAB
SECUKINUMAB is a biological associated with $18,637 in payments to 7 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $15,262 was paid across 16 transactions to 6 doctors.
The most common payment nature for SECUKINUMAB is "Travel and Lodging" ($8,530, 45.8% of total).
SECUKINUMAB is associated with 1 research study, including "Publication support research related" ($6,731).